Role of Vitamin C in COVID-19 Management: A Comprehensive Review

---

Vidhya C.S.¹ , Aniketa Sharma² , M. Sekhar³

¹Department of Primary Processing Storage and Handling, NIFTEM-Thanjavur, Thanjavur-613005, Tamil Nadu, India

²Department of Medicine, Dr. YSP Govt. Medical College Nahan District Sirmour H.P, India

³Department of Agronomy, CASAR, Bharatiya Engineering Science and Technology Innovation University, Andhra Pradesh-India

Corresponding Author Email: lllvidhyalll@gmail.com

DOI : https://doi.org/10.51470/APR.2023.2.2.15

Abstract

Keywords

Download this article as:

---

Introduction

The emergence of the novel coronavirus, SARS-CoV-2, and its subsequent manifestation as the COVID-19 pandemic have precipitated a global crisis of unprecedented proportions [1]. Since its identification in late 2019, the virus has rapidly spread across continents, challenging healthcare systems, economies, and societal norms. Amidst this turmoil, the quest for effective treatments and preventive measures has been fervent, driven by the urgency to alleviate the burden of disease and mitigate its impact on human health and well-being. In this pursuit, various therapeutic modalities have been explored, ranging from antiviral medications and immunomodulators to vaccines and supportive care strategies [2]. Among these, the potential role of vitamin C has garnered significant attention, owing to its diverse physiological functions and immunomodulatory properties. Vitamin C, also known as ascorbic acid, is a water-soluble micronutrient that plays essential roles in immune function, antioxidant defense, and cellular metabolism [3].

The rationale for investigating the therapeutic potential of vitamin C in the context of COVID-19 stems from its multifaceted mechanisms of action. As a potent antioxidant, vitamin C scavenges free radicals and reactive oxygen species, thereby protecting cells from oxidative damage and maintaining redox homeostasis. Furthermore, vitamin C modulates immune responses by enhancing the function of various immune cells, including neutrophils, macrophages, and lymphocytes, and regulating the production of cytokines and chemokines involved in host defense mechanisms [4]. In addition to its antioxidative and immunomodulatory effects, vitamin C exhibits anti-inflammatory properties, which are particularly relevant in the context of COVID-19 pathogenesis. Severe cases of COVID-19 are characterized by dysregulated immune responses and excessive inflammation, often culminating in acute respiratory distress syndrome (ARDS) and multiorgan failure. By inhibiting the production of pro-inflammatory mediators and modulating signaling pathways implicated in inflammation, vitamin C may attenuate the severity of cytokine storm and mitigate tissue injury in critically ill patients. Despite the biological plausibility and theoretical rationale supporting the use of vitamin C in COVID-19 management, the clinical evidence remains inconclusive and controversial [5]. While some studies have reported beneficial effects of vitamin C supplementation, including reduced inflammatory markers, improved oxygenation, and shorter hospital stays, others have failed to demonstrate significant clinical outcomes. The heterogeneity in study designs, patient populations, and treatment protocols underscores the need for well-designed randomized controlled trials to elucidate the efficacy and safety of vitamin C in COVID-19 patients. In this comprehensive review, the aim to critically evaluate the existing literature on the role of vitamin C in COVID-19 management. By synthesizing data from preclinical studies, clinical trials, and observational analyses, we seek to provide insights into the potential benefits and limitations of vitamin C supplementation as an adjunctive therapy for COVID-19 [6]. Through a rigorous examination of the available evidence, we endeavor to inform clinical practice, guide future research endeavors, and contribute to the global effort to combat the COVID-19 pandemic.

2. Immunomodulatory Effects of Vitamin C

Vitamin C, also known as ascorbic acid, plays a crucial role in modulating the immune response. It enhances the function of various immune cells, including neutrophils, macrophages, and lymphocytes, thereby promoting immune surveillance and defense against pathogens. Moreover, vitamin C regulates the production of cytokines and chemokines, which are integral components of the immune response to viral infections such as COVID-19. The immunomodulatory effects of vitamin C represent a pivotal aspect of its potential role in the management of COVID-19. Vitamin C, also known as ascorbic acid, is recognized for its ability to modulate various components of the immune system, thereby influencing host defense mechanisms against pathogens, including viruses like SARS-CoV-2 [7].

1. Enhancement of Immune Cell Function: Vitamin C plays a crucial role in supporting the function of innate and adaptive immune cells. Neutrophils, macrophages, and lymphocytes are key players in the immune response against viral infections. Vitamin C promotes the phagocytic activity of neutrophils, enhancing their ability to engulf and eliminate pathogens. Moreover, vitamin C enhances the differentiation and maturation of monocytes into macrophages, which are essential for antigen presentation and the clearance of viral particles. Additionally, vitamin C supports the proliferation and activation of T lymphocytes, facilitating the adaptive immune response and the generation of virus-specific cytotoxic T cells [8].

2. Regulation of Cytokine Production: Cytokines and chemokines are signaling molecules that orchestrate the immune response to viral infections. Vitamin C exerts regulatory effects on the production and secretion of cytokines, modulating the balance between pro-inflammatory and anti-inflammatory mediators. By inhibiting the synthesis of pro-inflammatory cytokines such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha), vitamin C may attenuate the cytokine storm observed in severe cases of COVID-19. Conversely, vitamin C enhances the production of anti-inflammatory cytokines such as interleukin-10 (IL-10), which help resolve inflammation and promote tissue repair [9].

3. Maintenance of Barrier Function: Vitamin C contributes to the integrity and function of epithelial barriers, including the respiratory mucosa, which serves as the primary site of viral entry for SARS-CoV-2. By enhancing the production of tight junction proteins and mucins, vitamin C strengthens epithelial barriers, reducing the likelihood of viral penetration and dissemination. Moreover, vitamin C stimulates the production of antimicrobial peptides, such as defensins, which possess direct antiviral properties and contribute to innate immune defense mechanisms [10].

4. Reduction of Oxidative Stress: Oxidative stress is a hallmark feature of viral infections, including COVID-19, characterized by an imbalance between reactive oxygen species (ROS) and antioxidant defenses. Vitamin C acts as a potent antioxidant, scavenging free radicals and neutralizing oxidative stress. By reducing oxidative damage to immune cells and tissues, vitamin C helps preserve immune function and prevent immune dysregulation associated with severe viral infections, the immunomodulatory effects of vitamin C are multifaceted and encompass enhancement of immune cell function, regulation of cytokine production, maintenance of barrier function, and reduction of oxidative stress. These mechanisms collectively contribute to the ability of vitamin C to modulate the immune response to viral infections, including COVID-19. However, further research is needed to elucidate the specific effects of vitamin C supplementation on immune function in COVID-19 patients and to determine its optimal role as an adjunctive therapy in the management of the disease [11].

Antioxidative Properties of Vitamin C:

One of the hallmark features of COVID-19 pathogenesis is oxidative stress, characterized by an imbalance between reactive oxygen species (ROS) and antioxidant defenses. Vitamin C acts as a potent antioxidant, scavenging free radicals and protecting cells from oxidative damage. By maintaining redox homeostasis, vitamin C may help alleviate tissue injury and inflammation associated with severe COVID-19. The antioxidative properties of vitamin C represent a crucial aspect of its potential role in the management of COVID-19. Ascorbic acid, commonly known as vitamin C, is a powerful water-soluble antioxidant that plays a pivotal role in neutralizing reactive oxygen species (ROS) and protecting cells from oxidative damage. In the context of viral infections such as COVID-19, oxidative stress contributes to disease pathogenesis and progression, making the antioxidative properties of vitamin C particularly relevant [12].

1. Scavenging of Free Radicals: Vitamin C acts as a potent scavenger of free radicals, including superoxide anion, hydroxyl radical, and singlet oxygen. Free radicals are highly reactive molecules that can damage cellular components, including proteins, lipids, and DNA, through oxidation. By donating electrons to neutralize free radicals, vitamin C helps prevent oxidative damage to biomolecules and maintain cellular homeostasis [13].

2. Regeneration of other Antioxidants: Vitamin C plays a key role in the regeneration of other antioxidants, including vitamin E and glutathione. Vitamin E, a fat-soluble antioxidant, protects cell membranes from lipid peroxidation induced by free radicals. Vitamin C regenerates oxidized vitamin E back to its active form, thereby sustaining its antioxidative activity within cell membranes. Similarly, vitamin C regenerates reduced glutathione, a critical intracellular antioxidant involved in detoxification and ROS scavenging [14].

3. Protection against Oxidative Stress: Oxidative stress, characterized by an imbalance between ROS production and antioxidant defenses, contributes to tissue injury and inflammation in COVID-19. Viral infection induces the production of ROS through various mechanisms, including activation of NADPH oxidase and mitochondrial dysfunction. Excessive ROS generation leads to oxidative damage to cellular structures and organelles, exacerbating tissue injury and promoting inflammatory responses. Vitamin C helps mitigate oxidative stress by scavenging ROS and enhancing antioxidant capacity, thereby protecting cells and tissues from oxidative damage associated with viral infections [15].

4. Preservation of Endothelial Function: Endothelial dysfunction is a hallmark feature of severe COVID-19 and is associated with increased oxidative stress and inflammation. Vitamin C plays a crucial role in preserving endothelial function by enhancing nitric oxide bioavailability and reducing oxidative stress-mediated endothelial injury. By maintaining vascular integrity and microcirculatory perfusion, vitamin C may mitigate tissue hypoxia and organ dysfunction in COVID-19 patients, the antioxidative properties of vitamin C are integral to its potential therapeutic effects in the management of COVID-19. By scavenging free radicals, regenerating other antioxidants, and protecting against oxidative stress-induced damage, vitamin C helps maintain cellular homeostasis and preserve tissue function during viral infections. However, further research is needed to elucidate the specific mechanisms underlying the antioxidative effects of vitamin C in COVID-19 and to determine its optimal role as an adjunctive therapy in the management of the disease [16].

Role of Vitamin C in Inflammation:

Excessive inflammation, often referred to as cytokine storm, is a major driver of morbidity and mortality in severe cases of COVID-19. Vitamin C exerts anti-inflammatory effects by inhibiting the production of pro-inflammatory mediators and modulating signaling pathways involved in inflammation. Furthermore, vitamin C enhances endothelial function and microcirculatory perfusion, which are critical in mitigating tissue damage and organ dysfunction in COVID-19 patients. The role of vitamin C in inflammation is a critical aspect of its potential efficacy in the management of COVID-19. Inflammation plays a central role in the pathogenesis of COVID-19, contributing to tissue injury, organ dysfunction, and severe clinical outcomes. Vitamin C exhibits anti-inflammatory properties through various mechanisms, which may help attenuate the dysregulated immune response and mitigate the severity of inflammation in COVID-19 patients [17].

1. Inhibition of Pro-inflammatory Mediators: Vitamin C modulates the production and release of pro-inflammatory mediators, including cytokines, chemokines, and reactive oxygen species (ROS). In COVID-19, dysregulated immune responses lead to the excessive production of pro-inflammatory cytokines, such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha), culminating in a cytokine storm and systemic inflammation. Vitamin C inhibits the synthesis of pro-inflammatory cytokines and chemokines, thereby attenuating the inflammatory cascade and mitigating tissue damage [18].

2. Modulation of NF-kB Signaling Pathway: Nuclear factor-kappa B (NF-kB) is a key transcription factor involved in the regulation of inflammatory responses. Activation of NF-kB leads to the transcription of genes encoding pro-inflammatory cytokines, adhesion molecules, and inflammatory enzymes. Vitamin C inhibits NF-kB activation and nuclear translocation, thereby suppressing the expression of pro-inflammatory genes and dampening the inflammatory response. By modulating NF-kB signaling, vitamin C helps regulate the balance between pro-inflammatory and anti-inflammatory pathways, promoting the resolution of inflammation and tissue repair [19].

3. Protection against Oxidative Stress: Oxidative stress is closely intertwined with inflammation and contributes to the pathogenesis of COVID-19. Vitamin C acts as a potent antioxidant, scavenging free radicals and neutralizing oxidative stress. By reducing ROS production and lipid peroxidation, vitamin C attenuates oxidative damage to cellular structures and organelles, thereby mitigating inflammation and tissue injury. Moreover, vitamin C enhances the activity of endogenous antioxidants, such as glutathione, further enhancing cellular defense mechanisms against oxidative stress [20].

4. Preservation of Endothelial Function: Endothelial dysfunction is a hallmark feature of severe COVID-19 and is characterized by impaired vascular integrity, microvascular thrombosis, and disseminated intravascular coagulation (DIC). Vitamin C plays a crucial role in preserving endothelial function by enhancing nitric oxide bioavailability, inhibiting endothelial activation, and preventing platelet aggregation. By maintaining vascular homeostasis and microcirculatory perfusion, vitamin C may help mitigate endothelial dysfunction and thrombotic complications associated with COVID-19, the anti-inflammatory effects of vitamin C are multifaceted and encompass inhibition of pro-inflammatory mediators, modulation of NF-kB signaling, protection against oxidative stress, and preservation of endothelial function. These mechanisms collectively contribute to the ability of vitamin C to attenuate inflammation, mitigate tissue injury, and improve clinical outcomes in COVID-19 patients. However, further research is needed to elucidate the specific effects of vitamin C supplementation on inflammation in COVID-19 and to determine its optimal role as an adjunctive therapy in the management of the disease [21].

5. Clinical Evidence and Trials:

Several clinical studies and trials have investigated the efficacy of vitamin C supplementation in COVID-19 patients. While some studies have reported beneficial effects, including reduced inflammatory markers and improved clinical outcomes, others have yielded inconclusive results. The heterogeneity in study designs, patient populations, and treatment protocols underscores the need for well-designed randomized controlled trials to elucidate the role of vitamin C in COVID-19 management.

Clinical evidence and trials investigating the efficacy of vitamin C supplementation in the management of COVID-19 have generated considerable interest and controversy. While preclinical studies and observational data have suggested potential benefits of vitamin C in mitigating inflammation, reducing oxidative stress, and improving clinical outcomes, the findings from clinical trials have been mixed and inconclusive [22].

1. Observational Studies and Case Reports: Several observational studies and case reports have reported favorable outcomes associated with vitamin C supplementation in COVID-19 patients. These studies have documented reduced inflammatory markers, improved oxygenation, and shorter hospital stays in patients receiving vitamin C therapy. However, observational studies are susceptible to bias and confounding factors, limiting the strength of the evidence and precluding causal inference [23].

2. Randomized Controlled Trials (RCTs): The results from randomized controlled trials investigating the efficacy of vitamin C supplementation in COVID-19 patients have been heterogeneous and conflicting. Some RCTs have reported positive effects of vitamin C supplementation, including reduced severity of illness, decreased inflammatory markers, and improved clinical outcomes. However, other trials have failed to demonstrate significant benefits of vitamin C therapy in COVID-19 patients, with outcomes comparable to standard of care or placebo groups. The variability in study designs, patient populations, and treatment protocols may contribute to the discrepant findings observed across different trials [24].

3. Methodological Challenges: Several methodological challenges pose limitations to the interpretation of clinical trials evaluating the efficacy of vitamin C supplementation in COVID-19. These challenges include variability in dosing regimens, route of administration, treatment duration, and patient selection criteria. Moreover, the heterogeneity in disease severity, comorbidities, and concomitant treatments among study participants may confound the outcomes and undermine the internal validity of the trials. Despite the inconclusive evidence from clinical trials, the potential role of vitamin C as an adjunctive therapy in the management of COVID-19 warrants further investigation. Future research endeavors should prioritize well-designed, multicenter, randomized controlled trials with standardized protocols to elucidate the efficacy, safety, and optimal dosing regimens of vitamin C supplementation in COVID-19 patients. Additionally, studies exploring the potential synergistic effects of vitamin C with other therapeutic agents and the identification of patient subgroups most likely to benefit from vitamin C therapy are needed to inform clinical practice and guide treatment decisions, while preliminary evidence suggests potential benefits of vitamin C supplementation in COVID-19 management, the current literature remains inconclusive and warrants cautious interpretation. Further research is needed to clarify the role of vitamin C in mitigating inflammation, reducing oxidative stress, and improving clinical outcomes in COVID-19 patients. Collaborative efforts involving clinicians, researchers, and public health authorities are essential to address the existing knowledge gaps, advance scientific understanding, and optimize therapeutic strategies for combating the COVID-19 pandemic [25].

Conclusion

In conclusion, the comprehensive review of the role of vitamin C in the management of COVID-19 underscores its potential as an adjunctive therapy in mitigating the severity of the disease and improving clinical outcomes. Vitamin C exerts diverse physiological effects, including immunomodulation, anti-oxidation, and anti-inflammatory properties, which are integral to combating the pathogenesis of COVID-19. The immunomodulatory effects of vitamin C enhance immune cell function, regulate cytokine production, and maintain barrier integrity, thereby promoting host defense mechanisms against viral infections. Additionally, the antioxidative properties of vitamin C help neutralize reactive oxygen species, protect against oxidative stress, and preserve cellular homeostasis in the face of viral-induced damage, vitamin C exhibits anti-inflammatory effects by inhibiting pro-inflammatory mediators, modulating NF-kB signaling, and preserving endothelial function, which are crucial in attenuating the dysregulated immune response and mitigating tissue injury associated with severe COVID-19.

While observational studies and preclinical data suggest potential benefits of vitamin C supplementation, the evidence from clinical trials remains inconclusive and heterogeneous. Methodological challenges, variability in study designs, and patient populations pose limitations to the interpretation of existing literature and underscore the need for well-designed randomized controlled trials to elucidate the efficacy, safety, and optimal dosing regimens of vitamin C in COVID-19 patients. Despite the current uncertainties, the potential of vitamin C as a therapeutic adjunct in COVID-19 management warrants further investigation. Collaborative research efforts, guided by rigorous scientific inquiry and clinical evidence, are essential to clarify the role of vitamin C in combating the COVID-19 pandemic and improving patient outcomes, while vitamin C holds promise as a potential therapeutic agent in the management of COVID-19, its true efficacy and clinical utility require validation through robust clinical trials and evidence-based practice. By advancing our understanding of the immunomodulatory, antioxidative, and anti-inflammatory effects of vitamin C, we can pave the way for more effective therapeutic strategies and interventions to combat the global health crisis posed by COVID-19.

References

• Abobaker, A., Alzwi, A., & Alraied, A. H. A. (2020). Overview of the possible role of vitamin C in management of COVID-19. Pharmacological Reports, 72(6), 1517-1528.
• Rawat, D., Roy, A., Maitra, S., Gulati, A., Khanna, P., & Baidya, D. K. (2021). Vitamin C and COVID-19 treatment: A systematic review and meta-analysis of randomized controlled trials. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 15(6), 102324.
• Migliorini, F., Vaishya, R., Eschweiler, J., Oliva, F., Hildebrand, F., & Maffulli, N. (2022). Vitamins C and D and COVID-19 susceptibility, severity and progression: an evidence based systematic review. Medicina, 58(7), 941.
• Olczak-Pruc, Monika, Damian Swieczkowski, Jerzy R. Ladny, Michal Pruc, Raul Juarez-Vela, Zubaid Rafique, Frank W. Peacock, and Lukasz Szarpak. “Vitamin C supplementation for the treatment of COVID-19: A systematic review and meta-analysis.” Nutrients 14, no. 19 (2022): 4217.
• Cerullo, G., Negro, M., Parimbelli, M., Pecoraro, M., Perna, S., Liguori, G.,& D’Antona, G. (2020). The long history of vitamin C: from prevention of the common cold to potential aid in the treatment of COVID-19. Frontiers in immunology, 11, 2636.
• Schloss, J., Lauche, R., Harnett, J., Hannan, N., Brown, D., Greenfield, T., & Steel, A. (2020). Efficacy and safety of vitamin C in the management of acute respiratory infection and disease: A rapid review. Advances in Integrative Medicine, 7(4), 187-191.
• Ao, G., Li, J., Yuan, Y., Wang, Y., Nasr, B., Bao, M., & Qi, X. (2022). Intravenous vitamin C use and risk of severity and mortality in COVID‐19: a systematic review and meta‐analysis. Nutrition in Clinical Practice, 37(2), 274-281.
• Farjana, M., Moni, A., Sohag, A. A. M., Hasan, A., Hannan, M. A., Hossain, M. G., & Uddin, M. J. (2020). Repositioning vitamin C as a promising option to alleviate complications associated with COVID-19. Infection & chemotherapy, 52(4), 461.
• Rezaei, H., Khiali, S., Rezaee, H., Bannazadeh Baghi, H., Pourghasem, M., & Entezari-Maleki, T. (2021). Potential roles of vitamins in the management of COVID-19: A comprehensive review. Pharmaceutical Sciences.
• Kwak, S. G., Choo, Y. J., & Chang, M. C. (2022). The effectiveness of high-dose intravenous vitamin C for patients with coronavirus disease 2019: A systematic review and meta-analysis. Complementary Therapies in Medicine, 64, 102797.
• Vollbracht, C., & Kraft, K. (2021). Feasibility of vitamin C in the treatment of post viral fatigue with focus on long COVID, based on a systematic review of IV vitamin C on fatigue. Nutrients, 13(4), 1154.
• Huang, L., Wang, L., Tan, J., Liu, H., & Ni, Y. (2021). High-dose vitamin C intravenous infusion in the treatment of patients with COVID-19: a protocol for systematic review and meta-analysis. Medicine, 100(19).
• Juneja, D., Gupta, A., Kataria, S., & Singh, O. (2022). Role of high dose vitamin C in management of hospitalised COVID-19 patients: A minireview. World Journal of Virology, 11(5), 300.
• Holford, P., Carr, A. C., Zawari, M., & Vizcaychipi, M. P. (2021). Vitamin C intervention for critical COVID-19: A pragmatic review of the current level of evidence. Life, 11(11), 1166.
• Miranda-Massari, J. R., Toro, A. P., Loh, D., Rodriguez, J. R., Borges, R. M., Marcial-Vega, V., & Gonzalez, M. J. (2021). The effects of vitamin C on the multiple pathophysiological stages of COVID-19. Life, 11(12), 1341.
• Esakandari, Hanie, Mohsen Nabi-Afjadi, Javad Fakkari-Afjadi, Navid Farahmandian, Seyed-Mohsen Miresmaeili, and Elham Bahreini. “A comprehensive review of COVID-19 characteristics.” Biological procedures online 22, no. 1 (2020): 1-10.
• Huang, W. Y., Hong, J., Ahn, S. I., Han, B. K., & Kim, Y. J. (2022, December). Association of Vitamin C Treatment with clinical outcomes for COVID-19 patients: A systematic review and meta-analysis. In Healthcare (Vol. 10, No. 12, p. 2456). MDPI.
• Mahluji, S., Jalili, M., Ostadrahimi, A., Hallajzadeh, J., Ebrahimzadeh-Attari, V., & Saghafi-Asl, M. (2021). Nutritional management of diabetes mellitus during the pandemic of COVID-19: a comprehensive narrative review. Journal of Diabetes & Metabolic Disorders, 20, 963-972.
• Rasmussen, M. P. (2020). Vitamin C evidence for treating complications of COVID-19 and other viral infections. Orthomolecular Medicine News Service.
• James, P. T., Ali, Z., Armitage, A. E., Bonell, A., Cerami, C., Drakesmith, H. & Prentice, A. M. (2021). The role of nutrition in COVID-19 susceptibility and severity of disease: a systematic review. The Journal of nutrition, 151(7), 1854-1878.
• Gavrielatou, E., Xourgia, E., Xixi, N. A., Mantelou, A. G., Ischaki, E., Kanavou, A., & Siempos, I. I. (2022). Effect of vitamin C on clinical outcomes of critically ill patients with COVID-19: an observational study and subsequent meta-analysis. Frontiers in Medicine, 9, 814587.
• Ebrahimzadeh-Attari, V., Panahi, G., Hebert, J. R., Ostadrahimi, A., Saghafi-Asl, M., Lotfi-Yaghin, N., & Baradaran, B. (2021). Nutritional approach for increasing public health during pandemic of COVID-19: A comprehensive review of antiviral nutrients and nutraceuticals. Health Promotion Perspectives, 11(2), 119.
• Firouzi, S., Pahlavani, N., Navashenaq, J. G., Clayton, Z. S., Beigmohammadi, M. T., & Malekahmadi, M. (2022). The effect of Vitamin C and Zn supplementation on the immune system and clinical outcomes in COVID-19 patients. Clinical nutrition open science, 44, 144-154.
• da Silva Toscano, G. A., de Araújo, I. I., de Souza, T. A., Mirabal, I. R. B., & de Vasconcelos Torres, G. (2021). Vitamin C and D supplementation and the severity of COVID-19: A protocol for systematic review and meta-analysis. Medicine, 100(26).
• Holford, P., Carr, A. C., Jovic, T. H., Ali, S. R., Whitaker, I. S., Marik, P. E., & Smith, A. D. (2020). Vitamin C—An adjunctive therapy for respiratory infection, sepsis and COVID-19. Nutrients, 12(12), 3760.